Scythian Biosciences Corp Stock Canadian Securities Exchange
Equities
CA7840531007
Investment Management & Fund Operators
Sales 2022 | -235.54 -322.9 | Sales 2023 | -31.51 -43.2 | Capitalization | 6.26M 8.58M |
---|---|---|---|---|---|
Net income 2022 | -297M -407M | Net income 2023 | -34M -46.61M | EV / Sales 2022 | -188,347 x |
Net Debt 2022 | 24.76M 33.95M | Net cash position 2023 | 70.4M 96.51M | EV / Sales 2023 | 2,035,264 x |
P/E ratio 2022 |
-0.07
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.99% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Kania
CEO | Chief Executive Officer | - | 20-05-18 |
Deena Siblock
BRD | Director/Board Member | - | 23-02-26 |
Corporate Officer/Principal | - | 18-04-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mehdi Azodi
BRD | Director/Board Member | - | 23-02-26 |
Deena Siblock
BRD | Director/Board Member | - | 23-02-26 |
Jason Batista
BRD | Director/Board Member | - | 23-06-06 |
1st Jan change | Capi. | |
---|---|---|
+2.02% | 35.4B | |
+9.47% | 33.9B | |
+7.74% | 5.58B | |
0.00% | 3.1B | |
+17.92% | 2.94B | |
+9.93% | 2.85B | |
-19.13% | 2.24B | |
+4.02% | 1.24B | |
+5.99% | 1.16B |